These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 8012279

  • 1. Susceptibility to copper-enhanced autoxidation of VLDL+LDL fractions from diabetic patients.
    Gugliucci A, Menini T, Stahl AJ.
    Biochem Mol Biol Int; 1994 Jan; 32(1):139-47. PubMed ID: 8012279
    [Abstract] [Full Text] [Related]

  • 2. Peroxidation status of erythrocytes and apolipoprotein B containing lipoproteins in hypercholesterolemic subjects.
    Ozdemirler G, Oztezcan S, Toker G, Uysal M.
    Int J Vitam Nutr Res; 1997 Jan; 67(2):130-3. PubMed ID: 9129256
    [Abstract] [Full Text] [Related]

  • 3. Lower susceptibility of low density lipoprotein to in vitro oxidation in diabetic patients.
    Taus M, Ferretti G, Curatola G, Dousset N, Solèra ML, Valdiguie P.
    Biochem Int; 1992 Dec; 28(5):835-42. PubMed ID: 1288493
    [Abstract] [Full Text] [Related]

  • 4. Oxidation of remnant-like particles from serum of diabetic patients, patients with ischemic heart disease and normal subjects.
    Tamura M, Tanaka A, Yui K, Nakajima K, Numano F.
    Horm Metab Res; 1997 Aug; 29(8):398-402. PubMed ID: 9288578
    [Abstract] [Full Text] [Related]

  • 5. Lipoprotein peroxidation in adult psoriatic patients.
    Offidani AM, Ferretti G, Taus M, Simonetti O, Dousset N, Valdiguie P, Curatola G, Bossi G.
    Acta Derm Venereol Suppl (Stockh); 1994 Aug; 186():38-40. PubMed ID: 8073834
    [Abstract] [Full Text] [Related]

  • 6. HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients.
    Sanguinetti SM, Brites FD, Fasulo V, Verona J, Elbert A, Wikinski RL, Schreier LE.
    Diabetes Nutr Metab; 2001 Feb; 14(1):27-36. PubMed ID: 11345163
    [Abstract] [Full Text] [Related]

  • 7. Effects of Atorvastatin on LDL sub-fractions and peroxidation in type 1 diabetic patients: a randomised double-blind placebo-controlled study.
    Manuel-Y-Keenoy B, Van Campenhout C, Vertommen J, De Leeuw I.
    Diabetes Metab Res Rev; 2003 Feb; 19(6):478-86. PubMed ID: 14648807
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Consequences of treatment with dexamethasone in rats on the susceptibility of total plasma and isolated lipoprotein fractions to copper oxidation.
    Belkebir-Mesbah D, Bonnefont-Rousselot D, Frey-Fressart V, Moinard C, Delattre J, Vasson MP.
    Endocrine; 1999 Jun; 10(3):233-42. PubMed ID: 10484287
    [Abstract] [Full Text] [Related]

  • 10. Effect of fish oil on LDL oxidation and plasma homocysteine concentrations in health.
    Piolot A, Blache D, Boulet L, Fortin LJ, Dubreuil D, Marcoux C, Davignon J, Lussier-Cacan S.
    J Lab Clin Med; 2003 Jan; 141(1):41-9. PubMed ID: 12518167
    [Abstract] [Full Text] [Related]

  • 11. Lipoperoxidation and hemodialysis.
    Ramos R, Martínez-Castelao A.
    Metabolism; 2008 Oct; 57(10):1369-74. PubMed ID: 18803940
    [Abstract] [Full Text] [Related]

  • 12. [Effects of plasma very low density lipoprotein, low density lipoprotein and high density lipoprotein on platelet aggregation in endogenous hypertriglyceridemia].
    Deng Z, Liu B, Zhou J, Zhang Z, Liu Y, Bai H.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Oct; 34(4):704-7. PubMed ID: 14619587
    [Abstract] [Full Text] [Related]

  • 13. Increased oxidizability of plasma low density lipoprotein from patients with coronary artery disease.
    Chiu HC, Jeng JR, Shieh SM.
    Biochim Biophys Acta; 1994 Jan 11; 1225(2):200-8. PubMed ID: 8280789
    [Abstract] [Full Text] [Related]

  • 14. Effect of atorvastatin on apolipoprotein B100 containing lipoprotein metabolism in type-2 diabetes.
    Ouguerram K, Magot T, Zaïr Y, Marchini JS, Charbonnel B, Laouenan H, Krempf M.
    J Pharmacol Exp Ther; 2003 Jul 11; 306(1):332-7. PubMed ID: 12684543
    [Abstract] [Full Text] [Related]

  • 15. Apolipoprotein B carbonyl formation is enhanced by lipid peroxidation during copper-mediated oxidation of human low-density lipoproteins.
    Yan LJ, Lodge JK, Traber MG, Packer L.
    Arch Biochem Biophys; 1997 Mar 01; 339(1):165-71. PubMed ID: 9056246
    [Abstract] [Full Text] [Related]

  • 16. LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients.
    Lee SJ, Campos H, Moye LA, Sacks FM.
    Arterioscler Thromb Vasc Biol; 2003 May 01; 23(5):853-8. PubMed ID: 12637336
    [Abstract] [Full Text] [Related]

  • 17. Copper deficiency increases the susceptibility of lipoproteins and tissues to peroxidation in rats.
    Rayssiguier Y, Gueux E, Bussiere L, Mazur A.
    J Nutr; 1993 Aug 01; 123(8):1343-8. PubMed ID: 8336203
    [Abstract] [Full Text] [Related]

  • 18. Decreased susceptibility to copper-induced oxidation of rat-lipoproteins after fibrate treatment: influence of fatty acid composition.
    Vázquez M, Merlos M, Adzet T, Laguna JC.
    Br J Pharmacol; 1996 Mar 01; 117(6):1155-62. PubMed ID: 8882610
    [Abstract] [Full Text] [Related]

  • 19. Enhanced susceptibility of low-density lipoprotein to in vitro oxidation in type 1 and type 2 diabetic patients.
    Beaudeux JL, Guillausseau PJ, Peynet J, Flourie F, Assayag M, Tielmans D, Warnet A, Rousselet F.
    Clin Chim Acta; 1995 Aug 14; 239(2):131-41. PubMed ID: 8542651
    [Abstract] [Full Text] [Related]

  • 20. The effect of pharmacological supplementation with vitamin C on low-density lipoprotein oxidation.
    Wen Y, Cooke T, Feely J.
    Br J Clin Pharmacol; 1997 Jul 14; 44(1):94-7. PubMed ID: 9241103
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.